Hospital
Delray Medical Center, INC.
Delray Medical Center, INC. was paid $4.64M by Medicaid between Jan 2018 and Dec 2024, across 110 billing codes. Its largest line is 99283, emergency room visit (moderate) — 26% of everything it billed.
33Billing provider infoDELRAY MEDICAL CENTER, INC.
DELRAY BEACH, FL 33484
DELRAY BEACH, FL 33484
33aNPI1326078288assigned 07/04/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.64M
24GClaims191,756
24DCodes billed110
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#84 of 163
Median peer was paid$4.77M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,736 | $259K | |
| 2019 | 39,145 | $515K | |
| 2020 | 33,759 | $506K | |
| 2021 | 39,082 | $867K | |
| 2022 | 41,909 | $1.49M | |
| 2023 | 15,172 | $707K | |
| 2024incomplete | 3,953 | $293K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 15,547 | 12,693 | $1.19M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 10,758 | 8,749 | $697K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.4% | 6,677 | 5,393 | $437K |
| 70450 | Computed tomography, head or brain; without contrast material | 6.0% | 3,091 | 2,362 | $276K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.2% | 985 | 833 | $243K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4.7% | 1,378 | 1,112 | $217K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.9% | 8,897 | 6,525 | $180K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.9% | 2,580 | 2,265 | $179K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.3% | 3,282 | 2,438 | $155K |
| 80053 | Comprehensive metabolic panel | 3.0% | 6,075 | 4,603 | $141K |
| 72125 | Computed tomography, cervical spine; without contrast material | 2.3% | 1,320 | 974 | $104K |
| G0378 | Hospital observation service, per hour | 2.0% | 4,033 | 1,539 | $95K |
98 more codes
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2.0% | 2,211 | $93K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.6% | 4,489 | $76K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.3% | 4,478 | $60K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 429 | $35K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,037 | $31K |
| 81001 | <1% | 5,406 | $30K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,070 | $28K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,761 | $22K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 417 | $20K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 581 | $19K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 14,098 | $19K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,316 | $18K |
| 87070 | <1% | 1,116 | $16K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,155 | $16K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,280 | $16K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 794 | $15K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,115 | $15K |
| A9270 | Non-covered item or service | <1% | 3,689 | $14K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 5,105 | $11K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 408 | $10K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,737 | $10K |
| 85610 | <1% | 3,417 | $8K | |
| 85730 | <1% | 3,104 | $8K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,860 | $8K |
| 84703 | <1% | 3,333 | $8K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 14 | $8K |
| 72131 | <1% | 158 | $7K | |
| J2704 | Injection, propofol, 10 mg | <1% | 744 | $7K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 3,031 | $6K |
| 84484 | <1% | 4,038 | $6K | |
| 82962 | <1% | 1,471 | $5K | |
| 83735 | <1% | 3,396 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,740 | $4K |
| 85027 | <1% | 1,746 | $4K | |
| 80076 | <1% | 2,884 | $4K | |
| 73562 | <1% | 294 | $4K | |
| J3490 | Unclassified drugs | <1% | 33 | $4K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,646 | $3K |
| 71250 | <1% | 20 | $3K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,825 | $3K |
| 83690 | <1% | 2,687 | $3K | |
| 70486 | <1% | 34 | $3K | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 96 | $2K |
| A4217 | Sterile water/saline, 500 ml | <1% | 88 | $2K |
| 96376 | <1% | 1,307 | $2K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,296 | $2K |
| 97162 | <1% | 52 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,353 | $2K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 465 | $2K |
| 86850 | <1% | 695 | $2K | |
| 94664 | <1% | 653 | $2K | |
| 86901 | <1% | 990 | $2K | |
| 86900 | <1% | 990 | $2K | |
| 73030 | <1% | 151 | $2K | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 67 | $2K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 465 | $1K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 13 | $1K |
| 84702 | <1% | 101 | $1K | |
| 73610 | <1% | 117 | $1K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 39 | $1K |
| 73630 | <1% | 160 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 156 | $1K |
| 73110 | <1% | 33 | $736.95 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 547 | $486.95 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 723 | $422.80 |
| 73130 | <1% | 33 | $382.93 | |
| 85379 | <1% | 208 | $372.24 | |
| 83880 | <1% | 459 | $358.37 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 400 | $332.07 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 397 | $320.99 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 273 | $320.99 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 13 | $303.45 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 23 | $302.59 |
| 87040 | <1% | 320 | $264.42 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 343 | $255.96 |
| 87186 | <1% | 425 | $141.11 | |
| 87077 | <1% | 199 | $101.86 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 299 | $78.32 |
| 83605 | <1% | 282 | $39.25 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 217 | $23.94 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 201 | $19.56 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 98 | $12.03 |
| 87400 | <1% | 17 | $8.31 | |
| 82550 | <1% | 53 | $4.83 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 94 | $4.64 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 160 | $1.13 |
| 72170 | 0% | 32 | $0.00 | |
| 85652 | 0% | 16 | $0.00 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 0% | 112 | $0.00 |
| C1769 | Guide wire | 0% | 13 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 19 | $0.00 |
| 84100 | 0% | 236 | $0.00 | |
| S0028 | Injection, famotidine, 20 mg | 0% | 297 | $0.00 |
| 90715 | 0% | 13 | $0.00 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 0% | 47 | $0.00 |
| 80306 | 0% | 29 | $0.00 | |
| 81025 | 0% | 28 | $0.00 | |
| 87420 | 0% | 53 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCARTWRIGHT, MICHELLE (CFO)